4.6(top 5%)
impact factor
1.8K(top 10%)
73.1K(top 5%)
121(top 5%)
4.7(top 10%)
extended IF
all documents
doc citations
191(top 5%)

Top Articles

1Diffusion Tensor Imaging of the BrainNeurotherapeutics20072,186
2The Prevalence of DSM-IV Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic ReviewNeurotherapeutics20121,600
3Microglial Activation and Chronic NeurodegenerationNeurotherapeutics2010747
4Inflammation and Stroke: An OverviewNeurotherapeutics2016631
5Involvement of Pro- and Anti-Inflammatory Cytokines and Chemokines in the Pathophysiology of Traumatic Brain InjuryNeurotherapeutics2010564
6Role of Microglia in NeurotraumaNeurotherapeutics2010541
7Therapeutics for Alzheimer's Disease Based on the Metal HypothesisNeurotherapeutics2008512
8Glioma Subclassifications and Their Clinical SignificanceNeurotherapeutics2017471
9Cannabidiol as a Potential Treatment for Anxiety DisordersNeurotherapeutics2015453
10Molecular targets for antiepileptic drug developmentNeurotherapeutics2007427
11Molecular Targets of Cannabidiol in Neurological DisordersNeurotherapeutics2015413
12Astrocytes in Alzheimer's DiseaseNeurotherapeutics2010377
13Spinal Cord Injury Scarring and Inflammation: Therapies Targeting Glial and Inflammatory ResponsesNeurotherapeutics2018363
14Anxiety, Depression, and the Microbiome: A Role for Gut PeptidesNeurotherapeutics2018358
15Targeting Astrocyte Signaling for Chronic PainNeurotherapeutics2010348
16Functions of Astrocytes and their Potential As Therapeutic TargetsNeurotherapeutics2010329
17Microglial Activation in Stroke: Therapeutic TargetsNeurotherapeutics2010328
18Antioxidant Therapies for Traumatic Brain InjuryNeurotherapeutics2010318
19Medical Comorbidities in Autism: Challenges to Diagnosis and TreatmentNeurotherapeutics2010306
20Stroke Epidemiology: Advancing Our Understanding of Disease Mechanism and TherapyNeurotherapeutics2011304
21Ketone Bodies as a Therapeutic for Alzheimer's DiseaseNeurotherapeutics2008296
22Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and ManagementNeurotherapeutics2016296
23Gut Microbiota and the Neuroendocrine SystemNeurotherapeutics2018295
24Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical TrialsNeurotherapeutics2017294
25Reactive Astrocytes As Therapeutic Targets for CNS DisordersNeurotherapeutics2010291
26Classification of Sleep DisordersNeurotherapeutics2012288
27Responsive Cortical Stimulation for the Treatment of EpilepsyNeurotherapeutics2008282
28The Endocannabinoid System and its Modulation by PhytocannabinoidsNeurotherapeutics2015281
29Magnetic resonance imaging of myelinNeurotherapeutics2007269
30Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the BedsideNeurotherapeutics2009267
31Iron in chronic brain disorders: Imaging and neurotherapeutic implicationsNeurotherapeutics2007266
32Interleukin-1β Biosynthesis Inhibition Reduces Acute Seizures and Drug Resistant Chronic Epileptic Activity in MiceNeurotherapeutics2011260
33Mechanisms and Targets of Deep Brain Stimulation in Movement DisordersNeurotherapeutics2008258
34Reaction Time Variability in ADHD: A ReviewNeurotherapeutics2012255
35Mitochondrial DNA Depletion Syndromes: Review and Updates of Genetic Basis, Manifestations, and Therapeutic OptionsNeurotherapeutics2013255
36PPARγ Agonists as Therapeutics for the Treatment of Alzheimer's DiseaseNeurotherapeutics2008254
37A Progressive Mouse Model of Parkinson's Disease: The Thy1-aSyn (“Line 61”) MiceNeurotherapeutics2012248
38Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections—a Nationwide, Population-Based Cohort Study in TaiwanNeurotherapeutics2018248
39Clinical Trials in Traumatic Brain Injury: Past Experience and Current DevelopmentsNeurotherapeutics2010247
40TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic TargetsNeurotherapeutics2015246
41Cell Death Mechanisms and Modulation in Traumatic Brain InjuryNeurotherapeutics2010236
42Protective and Toxic Neuroinflammation in Amyotrophic Lateral SclerosisNeurotherapeutics2015236
43Diabetic Painful and Insensate Neuropathy: Pathogenesis and Potential TreatmentsNeurotherapeutics2009231
44Closed-loop Neurostimulation: The Clinical ExperienceNeurotherapeutics2014227
455-HT6 Receptor Antagonists as Novel Cognitive Enhancing Agents for Alzheimer's DiseaseNeurotherapeutics2008226
46Clinical Utility of EEG in Attention-Deficit/Hyperactivity Disorder: A Research UpdateNeurotherapeutics2012222
47Electrical Stimulation to Enhance Axon Regeneration After Peripheral Nerve Injuries in Animal Models and HumansNeurotherapeutics2016219
48Clinical neuroimaging using arterial spin-labeled perfusion magnetic resonance imagingNeurotherapeutics2007209
49Cannabinoids and EpilepsyNeurotherapeutics2015207
50Convection-Enhanced DeliveryNeurotherapeutics2017204